Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 20Phase 3 8Phase 1/2 7Phase 2/3 3Phase 4 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 12Refractory Solid Tumors 2Recurrence 2Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Neurologic Manifestations 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Liver Neoplasms 1Kidney Neoplasms 1HCC 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Radiosurgery 7lenvatinib 5Radiofrequency Ablation 5Electroporation 5Radiotherapy 3Patient Navigation 3Laparoscopy 3Hepatectomy 3Exercise 3sintilimab 2perflutren 2Surgical Procedures, Operative 2Standard of Care 2Proton Therapy 2Nutritional Status 2Magnetic Resonance Spectroscopy 2Liver Transplantation 2Injections 2Dextrins 2Cryosurgery 2Control Groups 2Bupivacaine 2Anesthesia, General 2toripalimab 1tislelizumab 1seocalcitol 1pembrolizumab 1motexafin gadolinium 1gadofosveset trisodium 1gadobutrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Liver Neoplasms × Sorafenib × Clear all
NCT01005875 2017-05-10

RAD 0901

University of Alabama at Birmingham

Phase NA Terminated
5 enrolled 11 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡